MELHO
Comments
This line is a ME-WEI derivative (ICLAC). DepMap metadata has been updated (as of 22Q2) to reflect this.Disease
Melanoma
Disease Subtype
MelanomaPrimary/Metastasis
Primary
MELHO sequenced and profiled in following datasets
Loss-of-function screens
CRISPR (DepMap Public 22Q4+Score, Chronos)RNAi (Achilles+DRIVE+Marcotte, DEMETER2)
RNAi (Achilles, DEMETER2)
RNAi (DRIVE, DEMETER2)
Omics Characterizations
Expression Public 22Q4Copy Number Public 22Q4
Hotspot Mutations
Damaging Mutations
Mutation
Fusion
Protein Array
Methylation (1kb upstream TSS)
Copy Number (Absolute)
Compound Viability screens
Drug sensitivity AUC (Sanger GDSC1)Drug sensitivity IC50 (Sanger GDSC1)
Drug sensitivity AUC (CTD^2)
Drug sensitivity (PRISM Repurposing Primary Screen)
Drug sensitivity AUC (PRISM Repurposing Secondary Screen)
Drug sensitivity replicate-level dose (CTD^2)
Drug sensitivity replicate-level dose (Sanger GDSC1)
Drug sensitivity dose-level (PRISM Repurposing Secondary Screen)
Drug sensitivity replicate-level dose (PRISM Repurposing Secondary Screen)
Mutation
Loading table...
Fusion
Loading table...